Clinical Trial Update: Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating escitalopram (Lexapro) for atypical depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Depression

Drugs mentioned

• Lexapro (escitalopram)

Snippet

Sponsor: Duke University | Conditions: Atypical Depression | Phase 3 | Status: COMPLETED